At the Cancer Science Institute, my role as a Pathologist harnesses my expertise in cancer research, particularly in the realm of PD-L1 biomarker analysis. Contributing to ground-breaking work, our team has advanced the understanding of immune checkpoint inhibitors in lung cancer, positioning us at the forefront of translational medicine.My competencies in histology and immunology, refined over years of dedicated research, enable me to contribute significantly to the field of medical oncology. With a focus on precision oncology, I am committed to improving patient outcomes through the integration of molecular diagnostics and targeted therapy strategies.